Dermatology Education Hub

Wednesday, November 4, 2020  |  6:30 PM – 8:00 PM ET Psoriatic arthritis (PsA) is a chronic, inflammatory, musculoskeletal disease with a significant impact on quality of life and functional ability. Despite the data showing the overall impact of PsA, delays in diagnosis are common, which can lead to long-term joint damage and functional disability. In this CME Outfitters Live and OnDemand activity, expert faculty will focus on assessment, treatment, and management strategies to provide patients with the best treatment aligned with evolving evidence and expert recommendations.

Psoriasis (PsO) is a chronic, inflammatory skin disorder affecting about 1%-3% of the world’s population. There are many challenges in diagnosing and successfully managing individuals with PsO. For example, while there are similarities in PsO among ethnic groups, there are notable differences in presentation, quality of life, and treatment of PsO in people with skin of color.

The first episode of this four-episode CME Outfitters BriefCase learning series includes a video clinical encounter on differentiating PsO in people with skin of color, based on notable differences in disease presentation.

Psoriasis (PsO) and psoriatic arthritis (PsA) are complex disorders that require coordinated care between dermatologists and rheumatologists. Challenges to effective management include a lack of education of patients and health care providers (HCPs), suboptimal communication, and clinicians’ lack of a holistic treatment approach.

The third episode of this BriefCase series on challenging cases in PsO and PsA features a physician-patient office scenario video on educating the patient and strategies to coordinate care between specialists, as well as between specialists and primary care, with a goal of optimizing patient outcomes.

Participate Now

 Shingles, or herpes zoster, is a common secondary infection for older patients. Almost all individuals over the age of 50 are latently infected with varicella zoster virus (VZV) and therefore are at risk of developing shingles with reactivation of latent VZV. Individuals who develop shingles often experience debilitating postherpetic neuralgia (PHN), secondary skin infections, eye problems, or neurologic conditions including an increased risk of stroke. Despite the existence of vaccines, the number of people vaccinated for shingles remains low. In large part, this is due to the majority of individuals being unaware that a vaccine exists, as clinicians often fail to initiate discussion about it. This CME Outfitters Live and OnDemand webcast will focus on the burden imposed by shingles, improving uptake of vaccination and series completion for shingles through patient education, and applying real-world strategies to implement shingles immunization protocols.

In this interactive CMEO On Demand webcast, leading experts in the management of psoriasis will utilize clinical cases to illustrate real-life approaches that learners can apply in order to optimize incorporation of these latest recommendations into clinical practice.

In this CME Outfitters On Demand, expert faculty will discuss how best to include digital health coaching into clinical practice to reinforce patient education and provide critical guidance to patients.

In this CME Outfitters Live and On Demand, expert faculty will discuss diagnostic assessment and measurement of symptom severity in AD including patient-reported outcomes, with the goal of educating clinicians regarding tools for diagnosis and assessment that can be integrated into their clinical practice.

Participate Now

Atopic dermatitis (AD) is a challenging disease for both patients and healthcare providers. In this CME Outfitters recorded symposium expert faculty provide new insights into AD and will strengthen clinicians’ knowledge about the pathophysiology of AD, improve early diagnosis. and share practical insights, evidence and expertise about new agents for the treatment of AD.

Note: Credit Is No Longer Available

Several agents have been FDA-approved for the treatment of moderate-to-severe PsA since 2008, and there are still more currently under investigation. In this CME Outfitters Live and On Demand expert faculty will highlight the molecular targets of currently available and emerging biologic treatments for managing PsA, discuss individualized treatment plans, and provide updates on the latest clinical trials focused on the impact of long-term treatment, improving pain, and quality of life.

Note: Credit Is No Longer Available

Psoriasis is a common chronic inflammatory skin condition that affects 3% to 4% of adults in the United States. In this CME Outfitters webcast, participants are presented with a real-world case scenario intermixed with nationally-known, expert faculty discussing the latest clinical data, guidelines, and quality measures and how they apply to the case as we add layers of complexity to our patient scenario.

Note: Credit Is No Longer Available